West Pharmaceutical Services, Inc. (NYSE:WST) Shares Acquired by IFM Investors Pty Ltd
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Acquired by IFM Investors Pty Ltd
IFM Investors Pty Ltd increased its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating) by 14.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,788 shares of the medical instruments supplier's stock after buying an additional 1,654 shares during the quarter. IFM Investors Pty Ltd's holdings in West Pharmaceutical Services were worth $3,867,000 as of its most recent filing with the Securities and Exchange Commission.
IFM Investors Pty Ltd根據其最近提交給美國證券交易委員會的Form 13F文件，在第二季度增持了West Pharmtics Services，Inc.(紐約證券交易所代碼：WST-GET評級)的股票14.9%。該公司在本季度額外購買了1,654股後，持有這家醫療器械供應商的12,788股股票。截至最近提交給美國證券交易委員會的文件，IFM Investors Pty Ltd在West Pharmtics Services持有的股份價值386.7萬美元。
Several other large investors have also recently added to or reduced their stakes in WST. BlackRock Inc. lifted its position in West Pharmaceutical Services by 8.9% during the fourth quarter. BlackRock Inc. now owns 8,094,288 shares of the medical instruments supplier's stock worth $3,796,302,000 after buying an additional 664,275 shares during the period. Norges Bank purchased a new position in shares of West Pharmaceutical Services in the 4th quarter worth about $307,506,000. Bank of America Corp DE raised its holdings in shares of West Pharmaceutical Services by 36.7% in the 1st quarter. Bank of America Corp DE now owns 639,632 shares of the medical instruments supplier's stock worth $262,703,000 after purchasing an additional 171,554 shares during the period. Fiera Capital Corp raised its holdings in shares of West Pharmaceutical Services by 3,441.3% in the 1st quarter. Fiera Capital Corp now owns 86,762 shares of the medical instruments supplier's stock worth $35,634,000 after purchasing an additional 84,312 shares during the period. Finally, Vanguard Group Inc. raised its holdings in shares of West Pharmaceutical Services by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 8,716,312 shares of the medical instruments supplier's stock worth $3,579,876,000 after purchasing an additional 82,459 shares during the period. 91.98% of the stock is currently owned by hedge funds and other institutional investors.
其他幾家大型投資者最近也增持或減持了WST的股份。第四季度，貝萊德股份有限公司將其在西部醫藥服務公司的持股比例提高了8.9%。貝萊德股份有限公司在此期間增持了664,275股，目前持有這家醫療器械供應商8,094,288股股票，價值3,796,302,000美元。挪威銀行在第四季度購買了西方製藥服務公司的新頭寸，價值約307,506,000美元。第一季度，美國銀行(Bank Of America Corp DE)將其持有的西方製藥服務公司的股票增加了36.7%。美國銀行DE目前持有639,632股這家醫療器械供應商的股票，價值262,703,000美元，在此期間又購買了171,554股。Fiera Capital Corp在第一季度增持了3,441.3%的西方製藥服務公司的股票。Fiera Capital Corp目前持有這家醫療器械供應商的86,762股股票，價值35,634,000美元，在此期間又購買了84,312股。最後，先鋒集團(Vanguard Group Inc.)在第一季度增持了西部醫藥服務公司的股票1.0%。先鋒集團現在持有這家醫療器械供應商的8,716,312股股票，價值3,579,876,000美元，在此期間又購買了82,459股。91.98%的股票目前由對衝基金和其他機構投資者持有。
West Pharmaceutical Services Stock Performance
西部醫藥服務公司股票表現
West Pharmaceutical Services stock opened at $254.24 on Friday. The stock's 50-day moving average is $309.28 and its 200-day moving average is $327.42. The company has a market cap of $18.83 billion, a price-to-earnings ratio of 28.22, a price-to-earnings-growth ratio of 1.03 and a beta of 1.18. The company has a debt-to-equity ratio of 0.09, a current ratio of 3.13 and a quick ratio of 2.41. West Pharmaceutical Services, Inc. has a 12 month low of $248.95 and a 12 month high of $475.00.
西部製藥服務公司的股票週五開盤報254.24美元。該股的50日移動均線切入位在309.28美元，200日移動均線切入位在327.42美元。該公司市值為188.3億美元，市盈率為28.22倍，市盈率為1.03倍，貝塔係數為1.18。該公司的債務權益比為0.09，流動比率為3.13，速動比率為2.41。West Pharmtics Services，Inc.的12個月低點為248.95美元，12個月高位為475.00美元。
Insider Transactions at West Pharmaceutical Services
西方醫藥服務公司的內幕交易
In related news, insider Silji Abraham sold 5,374 shares of the firm's stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $343.93, for a total transaction of $1,848,279.82. Following the sale, the insider now directly owns 3,201 shares in the company, valued at approximately $1,100,919.93. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 0.60% of the company's stock.
在相關新聞中，內部人士Silji Abraham在8月1日星期一的一筆交易中出售了5374股該公司的股票。股票以343.93美元的平均價格出售，總成交金額為1,848,279.82美元。出售後，這位內部人士現在直接擁有該公司3,201股，價值約1,100,919.93美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，該文件可通過這個環節。公司內部人士持有該公司0.60%的股份。
West Pharmaceutical Services Company Profile
西部醫藥服務公司簡介
(Get Rating)
(獲取評級)
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
西方製藥服務公司在美洲、歐洲、中東、非洲和亞太地區設計、製造和銷售可注射藥物和保健產品的容器和輸送系統。它分為兩個部分，專有產品和合同製造產品。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on West Pharmaceutical Services (WST)
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- 2 Semiconductor Stocks To Watch For Reversals
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- 免費獲取StockNews.com關於West Pharmtics Services(WST)的研究報告
- 華爾街對Datadog的熱情會帶來巨大的收益嗎？
- MarketBeat：回顧一週9/19-9/23
- 為什麼特斯拉的股票保持彈性？
- 需要關注的2只半導體類股走勢逆轉
- 好市多盈利後價格疲軟是買入的好時機嗎？
Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating).
想看看還有哪些對衝基金持有WST嗎？訪問HoldingsChannel.com獲取西方製藥服務公司(紐約證券交易所代碼：WST-GET Rating)的最新13F文件和內幕交易。
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.
接受《西部醫藥服務報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對West Pharmtics Services和相關公司的最新新聞和分析師評級的每日簡要摘要。